Please provide your email address to receive an email when new articles are posted on . First-line biparametric MRI testing increased the number of biopsies and overdiagnoses vs. first-line PSA ...

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

Risankizumab is an effective treatment option for patients with psoriatic arthritis (PsA), according to a recent meta-analysis. Risankizumab showed superior efficacy across multiple outcomes compared ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW ORLEANS -- ...

For patients with psoriatic arthritis, bimekizumab was more effective for treating cutaneous symptoms compared with many other available treatments and ranked highly among currently approved ...

"We believe that prescribing this combination in routine practice is viable when combined with shared decision-making and strict monitoring of side effects," write Michelle L. M. Mulder, MD, of the ...

Findings of a phase 2b study indicated that use of tildrakizumab was associated with significant improvements in joint and skin manifestations of patients with psoriatic arthritis (PsA), although ...

Please provide your email address to receive an email when new articles are posted on . Upadacitinib demonstrates comparable efficacy and safety as monotherapy or in combination with non-biologic ...

(Ivanhoe Newswire) The PSA test for prostate cancer is not always 100 percent accurate, but according to this study, the test is more reliable in men taking dutasteride (Avodart), a drug prescribed to ...